Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

Names, credit-card details and Social Security numbers are the currency of the dark net. Now, your DNA may be, too. Ancestry-tracing company 23andMe is offering five years of genetic-monitoring ...

Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. A preliminary TikTok deal proposes U.S. investors own 80% of its ...

White House press secretary Karoline Leavitt on Saturday revealed further details of a deal reached between the U.S. and China over control of the popular social media platform TikTok, sharing that ...

NEW YORK, July 9 (Reuters) - TikTok is preparing to launch a standalone app for U.S. users that is expected to operate on a separate algorithm and data system from its global app, laying the ...

Regeneron Pharmaceuticals on Monday announced it is buying 23andMe out of bankruptcy for $256 million – taking with it the company’s extensive trove of genetic samples and data. It will acquire ...

Tarrytown-based Regeneron would acquire 23andMe for $256 million under the deal that is pending approval by bankruptcy court and regulators. New York-based biotech giant Regeneron Pharmaceuticals ...

Editor’s note: This story has been updated to include 23andMe’s policy on its sale. We regret the error. The bankruptcy of genetic-testing company 23andMe puts ...

On a special episode (first released on April 16, 2025) of The Excerpt podcast: The recent bankruptcy of genetic testing firm 23andMe has raised alarm bells for privacy advocates and consumers worried ...

The openSNP project, a platform for sharing genetic and phenotypic data, will shut down on April 30, 2025, and delete all user submissions over privacy concerns and the risk of misuse by authoritarian ...